Renalytix Plc (RNLXY)
OTCMKTS · Delayed Price · Currency is USD
4.260
0.00 (0.00%)
Jan 27, 2026, 9:30 AM EST
Renalytix Revenue
In the fiscal year ending June 30, 2025, Renalytix had annual revenue of $3.00M with 30.43% growth. Renalytix had revenue of $522.00K in the quarter ending September 30, 2024, with 13.73% growth.
Revenue
3.00M
Revenue Growth
+35.07%
P/S Ratio
11.83
Revenue / Employee
n/a
Employees
102
Market Cap
35.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.00M | 700.00K | 30.43% |
| Jun 30, 2024 | 2.30M | -1.10M | -32.41% |
| Jun 30, 2023 | 3.40M | 433.00K | 14.58% |
| Jun 30, 2022 | 2.97M | 1.48M | 99.20% |
| Jun 30, 2021 | 1.49M | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MariMed | 157.38M |
| LakeShore Biopharma | 84.75M |
| Bioqual | 46.54M |
| High Country Bancorp | 23.02M |
| HFB Financial | 16.30M |
| Kidoz | 16.28M |
| Hocking Valley Bancshares | 10.89M |
Renalytix News
- 2 months ago - Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes - PRNewsWire
- 4 months ago - Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease - PRNewsWire
- 6 months ago - MVP Health Care and Renalytix Partner to Bring Life-Changing Kidney Disease Testing to Local Communities - PRNewsWire
- 11 months ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 year ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire